These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7289051)

  • 1. [Anticomplementary activity of cinnarizine, and the relationship between complement and arteriosclerosis].
    Yamauchi Y; Matsumoto J; Horimatsu T; Isobe T
    Nihon Rinsho; 1981 Jan; 39(1):195-9. PubMed ID: 7289051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoenzyme determination of the C5b-9 complex of the complement system].
    Rus H; Niculescu F; Cristea A; Vlaicu R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):35-40. PubMed ID: 3738363
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cinnarizine and phosphatidyl choline in the treatment of cerebral arteriosclerotic pathology and arteriosclerosis of the lower extremities. Comparative study].
    Ciammaichella A; Solitro A; Arcuri P
    Minerva Cardioangiol; 1975 Mar; 23(3):191-200. PubMed ID: 1128771
    [No Abstract]   [Full Text] [Related]  

  • 4. Atheroma cholesterol activates complement and aggregates granulocytes: possible role in ischemic manifestations of atherosclerosis.
    Greenberg CS; Hammerschmidt DE; Craddock PR; Jacob HS
    Trans Assoc Am Physicians; 1979; 92():130-5. PubMed ID: 398614
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of chronic urticaria with an inhibitor of complement activation (cinnarizine).
    Kalimo K; Jansen CT
    Ann Allergy; 1980 Jan; 44(1):34-7. PubMed ID: 7352689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of a single dose of cinnarizine on the peripheral flow and renogram of arteriosclerotic patients].
    Indovina I; Salerno L; Custro N
    Minerva Cardioangiol; 1980 May; 28(5):355-8. PubMed ID: 7207825
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of the complement system: a crucial link between inflammation and atherosclerosis?
    Kostner KM
    Eur J Clin Invest; 2004 Dec; 34(12):800-2. PubMed ID: 15606721
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trial of cinnarizine in some vascular diseases].
    Triandaf I; Cosma M; Triandaf N
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(1):19-22. PubMed ID: 135327
    [No Abstract]   [Full Text] [Related]  

  • 9. Action of a new non-steroid antiinflammatory drug, nimesulide, on activation of the complement system: an in vitro study.
    Auteri A; Saletti M; Blardi P; Di Perri T
    Int J Tissue React; 1988; 10(4):217-21. PubMed ID: 3250936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopharmacological examination of Stugeron (Cinnarizine) in geriatric patients.
    Graber H; Ternovszky E
    Ther Hung; 1978; 26(3):124-6. PubMed ID: 725815
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement activation in atherosclerosis: effect of angiography and surgery.
    Kalos A; Germenis A; Prountzos P; Kitas GD; Kalodiki E; Fertakis A; Balas P
    Int Angiol; 1988; 7(1):71-4. PubMed ID: 2968427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
    Reimann-Hunziker R; Reimann-Hunziker GJ
    Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
    [No Abstract]   [Full Text] [Related]  

  • 13. Salt-sensitivity of complement (C)-consumption induced by anticomplementary antigens and antigen/antibody complexes.
    Gancevici G; Popescu C; Toporan M
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):239-50. PubMed ID: 6818928
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sturgeron treatment effectiveness in early cerebral arteriosclerosis].
    Belonog RP; Karaban' IN
    Vrach Delo; 1980 Sep; (9):67-9. PubMed ID: 7423956
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the calcium antagonists perhexiline and cinnarizine on vascular and cardiac contractile protein function.
    Silver PJ; Dachiw J; Ambrose JM; Pinto PB
    J Pharmacol Exp Ther; 1985 Sep; 234(3):629-35. PubMed ID: 3162016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence.
    Bhakdi S; Torzewski M; Paprotka K; Schmitt S; Barsoom H; Suriyaphol P; Han SR; Lackner KJ; Husmann M
    Circulation; 2004 Apr; 109(15):1870-6. PubMed ID: 15037531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasickness treatment with cinnarizine.
    Dolmierski R
    Bull Inst Marit Trop Med Gdynia; 1983; 34(3-4):215-6. PubMed ID: 6681365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience in the treatment of leg ulcer with Stutgeron].
    Mund-Hoym WD
    Med Welt; 1976 Jun; 27(25):1251-4. PubMed ID: 933813
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of aligeron and cinnarizine on the behavior of experimental animals].
    Nikolova M; Stefanova D; Nikolov R
    Eksp Med Morfol; 1980; 19(4):212-6. PubMed ID: 7460809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement in vitro inhibition by a low-sulfate chondroitin sulfate (matrix).
    Biffoni M; Paroli E
    Drugs Exp Clin Res; 1991; 17(1):35-9. PubMed ID: 1833171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.